JANET FLINN: Open Payments
NPI 1073580171 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 28 payments from 14 companies in 2025. Trend: 2023 $838 · 2024 $694 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $201 |
| Janssen Biotech, Inc. | 2 | $145 |
| Novo Nordisk Inc | 1 | $121 |
| Axsome Therapeutics, Inc. | 3 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Antares Pharma, Inc. | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 2 | $31 |
| Insulet Corporation | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: FANAPT, TREMFYA, Ozempic, Auvelity, XYOSTED, REXULTI, TZIELD, Omnipod.
Industry payments across KY — which companies pay providers there.
